RM-END / Endocrine and peptide-hormone analogs
Desmopressin
Also known as: Desmopressin acetate · DDAVP · Vasopressin analog
Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.
What this is
Desmopressin is a modified analog of vasopressin. Injectable, oral and intranasal products are different finished presentations and should not be collapsed into one generic record.
Evidence position
FDA-labeled comparators support Grade A for the defined products.
What the record does not establish
The comparator labels do not verify the identity, concentration, sterility or suitability of another source.
Sources
- 01Desmopressin acetate injection prescribing informationDailyMed / U.S. National Library of Medicine
- Shows
- Current U.S. injectable-product label and boxed warning
- Does not show
- Does not describe other routes or independently sourced material
External database index
LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE
Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.
PUBCHEM / IDENTITY
Desmopressin
- CID
- 5311065
- Formula
- C46H64N14O12S2
- Mass
- 1069.2
PUBMED / FOUND RECORDS
- Desmopressin. / 2006PMID 30000372
- Desmopressin. / 2026 JanPMID 32119469
- Desmopressin and antifibrinolytics.International anesthesiology clinics / 1990 FallPMID 2228279 / DOI 10.1097/00004311-199002840-00009
- Management of treatment-resistant nocturnal enuresis.Pediatrics international : official journal of the Japan Pediatric Society / 2023 Jan-DecPMID 37428825 / DOI 10.1111/ped.15573
- Desmopressin treatment: current status.Scandinavian journal of urology and nephrology. Supplementum / 1999PMID 10573800 / DOI 10.1080/00365599950510274
CLINICALTRIALS.GOV / FOUND RECORDS
- Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)COMPLETED / NO PHASE / Ferring PharmaceuticalsNCT00902265 / DIRECT intervention MATCH: Desmopressin
- A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).COMPLETED / PHASE3 / Ferring PharmaceuticalsNCT01280188 / DIRECT intervention MATCH: Desmopressin
- Minirin Versus Oxybutynin for Nocturnal Enuresis in ChildrenCOMPLETED / PHASE3 / Hormozgan University of Medical SciencesNCT02538302 / DIRECT intervention MATCH: Desmopressin
- Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region TumorsENROLLING_BY_INVITATION / PHASE4 / Zhaoyun ZhangNCT07712328 / DIRECT intervention MATCH: Desmopressin
- Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D DeficiencyCOMPLETED / NA / Ain Shams UniversityNCT07292753 / DIRECT intervention MATCH: Desmopressin